Mounjaro (tirzepatide) Mounjaro ( tirzepatide ) is another medication with a dual-action mechanism , targeting GLP-1 and GIP receptors but, unlike retatrutide, it doesnt target glucagon receptors
During your consultation, be prepared to discuss : Your current diabetes control and any home blood glucose monitoring results Previous medication history and responses to different treatments Your breastfeeding intentions and duration goals Any family history of diabetes or metabolic conditions Lifestyle factors including diet, physical activity, and weight changes Your GP may arrange : HbA1c testing to assess overall glycaemic control Referral to a diabetes specialist nurse or consultant endocrinologist Dietitian consultation for medical nutrition therapy Postnatal diabetes review if you had gestational diabetes Remember that uncontrolled diabetes poses significant risks including cardiovascular disease, neuropathy, retinopathy, and nephropathy
Gupta explains this could be due to gut sensitivity, changes in the bodys fluid balance or existing medical conditions exacerbated by the drug
Yes, but the waiting period is typically longer, usually twelve to sixteen weeks, to allow adequate surgical healing
food and drug administration (FDA) adverse event reporting system (FAERS) database
Example: 10mg vial / 2mg per week = 5 weeks
